A promising new study from Mayo Clinic, in conjunction with Caris Life Sciences, points to immunotherapy as a possible treatment option for patients with the difficult-to-treat triple negative breast cancer mutation. The study was presented this week at the 50th annual meeting of the American Society of Clinical Oncology in Chicago.
“This study may change our ability to treat triple negative breast cancer patients,” says Barbara Pockaj, M.D., lead investigator of the study and Mayo Clinic surgeon. “We may have signs that these patients can be treated with immunotherapy. We don’t have a lot of options for these patients and this would really expand our options.”
http://JooTube.TV Israel’s bio-med research community…
For the full article:…
On April 28, 2016, Jonathan D. Schoenfeld, radiation…
Let us help fight cancer. Share your knowledge.
Latest news, views, insights and trends on cancer treatment, discovery and support